Title : ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer.

Pub. Date : 2008 Mar

PMID : 17905465






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In summary, we showed that a ERCC1-negative protein status was significantly related to tumor responsiveness to neoadjuvant chemotherapy with cisplatin and irinotecan, but such a status was not a clear prognostic predictor to cisplatin-based neoadjuvant therapy in NSCLC patients. Irinotecan ERCC excision repair 1, endonuclease non-catalytic subunit Homo sapiens